Skip to content
verana-health-logo-inverted
  • Clinicians
    • MIPS Advisory Offerings
    • Practice Insights
    • Verana Trial Connect
    • Verana Quality Measures
  • Life Sciences
    • Clinical Development
    • HEOR & Medical Affairs
    • Commercialization
  • Research
  • Therapeutic Area
    • Oncology
      • Acute Myeloid Leukemia
      • Breast Cancer
      • Chronic Lymphocytic Leukemia
      • Colorectal Cancer
      • Follicular Lymphoma
      • Large B-Cell Lymphoma
      • Lung Cancer
      • Marginal Zone Lymphoma
      • Melanoma
      • Multiple Myeloma
      • Myelodysplastic Syndrome
      • Ovarian Cancer
    • Ophthalmology
      • Anti-VEGF
      • Diabetic Retinopathy
      • Dry Eye Disease
      • Cataracts
      • Geographic Atrophy
      • Glaucoma
      • Neovascular AMD
      • Retinitis Pigmentosa
      • Thyroid Eye Disease
      • Uveitic Macular Edema
      • Qdata Explorer
    • Urology
      • Benign Prostatic Hyperplasia
      • Bladder Cancer
      • Prostate Cancer
    • Neurology
      • Multiple Sclerosis
      • Parkinson’s Disease
      • Spinal Muscular Atrophy
  • Solutions
    • Clinical Research Solutions
      • Trial Design
      • Protocol Optimization & Site Selection
      • Patient Recruitment
      • Prospective Evidence Generation (PEG)
    • Clinical Trials
      • Site Explorer
    • Market Insights
      • Market Tracking
      • Brand Switching
      • Prescriber Mapping
    • RWE Studies
      • Patient Segmentation
      • Safety Studies
      • Natural History of Disease / Disease Progression
      • Comparative Effectiveness
      • Treatment Patterns & Outcomes
      • Healthcare Resource Utilization (HCRU) Cost
    • Phase IV Studies / Surveillance
  • About Us
    • About
      • Evolve Registry
    • Team
    • Press
    • Blog
    • Careers
    • Partners
      • Societies
      • CROs
      • Technology and Data
    • Privacy
      • Privacy Policy
      • Patient Privacy
Contact Us

News

Advancing Drug Development and Regulatory Compliance with AI-Enhanced Real-World Evidence

February 18, 2025
Read More...

PharmaVoice’s Crystal Ball: Industry Shifts in R&D, Policy and Clinical Trials

January 27, 2025
Read More...

25 Executive Digital Health Predictions & Trends to Watch in 2025

January 27, 2025
Read More...

2025 Trends: Using Unstructured Data in Clinical Research

January 27, 2025
Read More...

2025 Trends: Leveraging Real-World Data for Synthetic Control Arms

January 27, 2025
Read More...

Leveraging Artificial Intelligence Alongside RWE/RWD

January 27, 2025
Read More...

Complimenting Traditional Research With Genomic Data in Urology

January 27, 2025
Read More...

Reaching Improved Outcomes With Multiple Data Sources

January 27, 2025
Read More...

Accelerating Drug Development With External Control Arms

January 27, 2025
Read More...

Industry Outlook for 2025 — Real-World Data

January 7, 2025
Read More...
  • 1
  • 2
  • 3
  • …
  • 7
  • Next »
verana-health-logo-inverted

© 2026 Verana Health. All Rights Reserved.

San Francisco
New York
Knoxville
  • Privacy Policy
  • Cookie Policy
Back to Top